XML 50 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Cash flows from operating activities:      
Net income $ 56,849 $ 27,670 $ 61,880
Loss from discontinued operations     100
Income from continuing operations 56,849 27,670 61,980
Adjustments to reconcile to net cash provided by operating activities:      
Depreciation and amortization 38,117 36,039 30,732
(Gain) loss on sale of fixed assets (785) (373) 73
Equity-based compensation expense 6,767 6,491 6,713
Deferred income taxes (2,933) (2,320) 8,024
Equity in earnings of affiliated companies (6,359) (3,471) (7,291)
Reversal of earnout (10,019) (1,700) (1,700)
(Gain) loss on foreign currency transactions 1,049 (1,155) 98
Other (2,272) 573 (1,246)
Changes in operating assets and liabilities (net of acquisitions):      
Restricted cash (1,492) 663 538
Return on equity of affiliated companies 11,034 7,018 7,803
Receivables net, retainage and costs and estimated earnings in excess of billings 5,397 (38,310) (39,214)
Inventories (3,661) (5,992) (9,677)
Prepaid expenses and other assets 3,338 2,045 (539)
Accounts payable and accrued expenses 14,826 (2,248) (3,781)
Other operating 865 (2,046) 962
Net cash provided by operating activities 110,721 22,884 53,475
Net cash used in operating activities of discontinued operations     (446)
Net cash provided by operating activities 110,721 22,884 53,029
Cash flows from investing activities:      
Capital expenditures (45,894) (21,554) (36,858)
Proceeds from sale of fixed assets 4,401 755 482
Patent expenditures (552) (1,130) (1,346)
Purchase of Singapore licensee     (1,257)
Net cash used in investing activities (83,418) (166,063) (38,979)
Cash flows from financing activities:      
Issuance of common stock upon stock option exercises, including tax benefit 1,178 3,610 2,302
Issuance of common stock in connection with acquisition of Fyfe North America   4,000  
Repurchase of common stock (12,308) (5,000)  
Investments from noncontrolling interests 4,939 546 2,578
Purchase of or distributions to noncontrolling interests (5) (1,661) (398)
Proceeds on notes payable 7,160 354 1,986
Principal payments on notes payable (2,768) (1,499) (1,808)
Proceeds from line of credit 26,000    
Proceeds from long-term debt 983 250,000  
Principal payments on long-term debt (25,000) (103,750) (10,000)
Credit facility and other financing fees   (4,320)  
Net cash provided by (used in) financing activities 179 142,280 (5,340)
Effect of exchange rate changes on cash 65 (7,801) 55
Net increase (decrease) in cash and cash equivalents for the period 27,547 (8,700) 8,765
Cash and cash equivalents, beginning of period 106,129 114,829 106,064
Cash and cash equivalents, end of period 133,676 106,129 114,829
Supplemental disclosures of cash flow information:      
Interest 7,945 17,231 7,046
Net income taxes paid 18,456 10,077 19,001
Fyfe LA [Member]
     
Adjustments to reconcile to net cash provided by operating activities:      
Reversal of earnout (300)    
Cash flows from investing activities:      
Business Acquisition (3,048)    
Fyfe Asia [Member]
     
Cash flows from investing activities:      
Business Acquisition (38,841)    
CRTS, Hockway and Fyfe NA [Member]
     
Cash flows from investing activities:      
Business Acquisition $ 516 $ (144,134)